Adjuvant effect of zymosan after pulmonary treatment in a mouse ovalbumin allergy model

Experimental Lung Research

Volumn 39, Issue 1, 2013, Pages 48-57

  Young, Shih Houng ^a   Wolfarth, Michael G ^a   Roberts, Jenny R ^a   Kashon, Michael L ^a   Antonini, James M ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

1 3 glucan; Allergy; Fungi; Inflammation; Zymosan

Indexed keywords

BETA 1,3 GLUCAN; IMMUNOGLOBULIN E; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 5; OVALBUMIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; EOSINOPHIL; EXPERIMENTAL MODEL; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LUNG LAVAGE; MALE; MOUSE; NASOPHARYNGEAL ASPIRATION; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SENSITIZATION; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; EOSINOPHILS; IMMUNOGLOBULIN E; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; SPECIFIC PATHOGEN-FREE ORGANISMS; ZYMOSAN;

EID: 84872740571     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2012.749960     Document Type: Article

References (43)

1. Soloman GM, Hjelmroos-Koski M, Rotkin-Ellma M Hammond SK: Airborne mold and endotoxin concentrations in New Orleans, Louisiana, after flooding, October through November 2005. Environ Health Perspect. 2006;114:1381-1386 (Pubitemid 44314761)
2. Institute of Medicine. Human health effects associated with damp indoor environments. In: Damp Indoor Spaces and Health. Washington, DC: National Academies Press; 2004:183-269
3. Centers for Disease Control and Prevention: Health concerns associated with mold in water-damaged homes after Hurricane Katrina and Rita, New Orleans area, Louisiana, October 2005 MMWR Morbid Mortal Wkly Rep. 2006;55:41-44
4. Bush RK, Portnoy JM, Terr AI, Wood RA: The medical effects of mold exposure. J Allergy Clin Immunol. 2006;117:326-333 (Pubitemid 43190147)
5. Park J-H, Cox-Ganser J, Rao C, Kreiss K: Fungal and endotoxin measurement in dust associated with respiratory symptoms in a water-damaged office building. Indoor Air. 2006;16:192-203 (Pubitemid 43943860)
6. Park J-H, Cox-Ganser JM, Kreiss K, White SK, Rao CY: Hydrophilic fungi and ergosterol associated with respiratory illness in a water-damaged building. Environ Health Perspect. 2008;116:45-50
7. Rylander R: Investigations of the relationship between disease and airborne (1→3)-β-D-glucan in buildings. Mediators Inflamm. 1997;6:275-277 (Pubitemid 28004763)
8. DiCarlo FJ, Fiore JV: On the composition of zymosan. Science. 1957;127:756-757
9. Young S-H, Robinson VA, Barger M, Porter DW, Frazer DG Castranova V: Acute inflammation and recovery in rats after intratracheal instillation of a 1→3-β-glucan (Zymosan A). J Toxicol Environ Health A. 2001;64:311-325 (Pubitemid 32989445)
10. Young S-H, Roberts JR, Antonini JM: Pulmonary exposure to 1→3-β-glucan alters adaptive immune responses in rats. Inhal Toxicol. 2006;18:865-874 (Pubitemid 44180254)
11. Young S-H, Antonini JM, Roberts JR: Single pre-exposure to high dose of zymosan enhances lung defense mechanisms and accelerates the pulmonary clearance of a bacterial pathogen in rats. Exp Lung Res. 2008;34:559-578
12. Young S-H, Antonini JM, Roberts JR: Preexposure to repeated low doses of zymosan increases the susceptibility to pulmonary infection in rats. Exp Lung Res. 2009;35:570- 590
13. Young S-H, Ostroff GR, Zeidler-Erdely PC, Roberts JR, Antonini JM, Castranova V: A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J Toxicol Environ Health. 2007;70:116-124
14. Wan G-H, Li C-S, Guo S-P, Rylander R, Lin R-H: An airborne mold-derived product, β-1,3-D-glucan, potentiates airway allergic responses. Eur J Immunol. 1999;29:2491-2497 (Pubitemid 29378119)
15. Ormstad H, Groeng E-C, Lovik M, Hetland G: The fungal cell wall component β-1,3-glucan has an adjuvant effect on the allergic response to ovalbumin in mice. J Toxicol Environ Health A. 2000;61:55-67
16. Instanes C, Ormstad H, Rydjord B, Wiker HG, Hetland G: Mould extracts increase the allergic response to ovalbumin in mice. Clin Exp Allergy. 2004;34:1634-1641 (Pubitemid 39389343)
17. Pauluhn J, Mohr U: Experimental approaches to evaluate respiratory allergy in animal models. Exp Toxicol Pathol. 2005;56:203-234 (Pubitemid 40312747)
18. Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML Salmen R, Battelli LA, Willard PA, Hoover MD, Hubbs AF: Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A. 2003;66:1441-1452 (Pubitemid 36976208)
19. Hogan MB, Weissman DN, Hubbs AF, Gibson LF, Piktel D, Landreth KS: Regulation of eosinophilopoiesis in a murine model of asthma. J Immunol. 2003;171:2644- 2651 (Pubitemid 37025578)
20. Stevens WW, Kim TS, Pujanauski LM, Hao X, Braciale TJ: Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J Immunol Methods. 2007;327: 63-74 (Pubitemid 47444310)
21. Rylander R, Holt PG: (1→3)-β-D-glucan and endotoxin modulate immune response to inhaled allergen.Mediators Inflamm. 1998;7:105-110 (Pubitemid 28238122)
22. Katelaris CH, Linneberg A, Magnan A, Thomas WR, Wardlaw AJ,Wark P:Developments in the field of allergy in 2010 through the eyes of Clinical and Experimental Allergy. Clin Exp Allergy. 2011;41:1690-1710
23. Inman MD: Bone marrow events in animal models of allergic inflammation and hyperresponsiveness. J AllergyClin Immunol. 2000;106:S235-S241
24. Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP: Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy. 2012;42:712-737
25. Poon AH, Eidelman DH, Martin JG, Laprise C, Hamid Q: Pathogenesis of severe asthma. Clin Exp Allergy. 2012;42:625-637
26. Young S-H, Robinson VA, Barger M, Whitmer M, Porter DW, Frazer DG, Castranova V: Exposure to particulate 1→3-β-glucan induces greater pulmonary toxicity than soluble 1->3-beta-glucans in rats. J Toxicol Environ Health A. 2003;66:25-38 (Pubitemid 36026869)
27. Rylander R: Organic dust induced pulmonary disease: The role of mould derived B-glucan. Ann Agric Environ Med. 2010:17:9-13
28. Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM: Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded β-glucan particles. mBio. 2010;1(3):e00164-10
29. Martinez JP, Gil ML, Lopez-Ribot JL, Chaffin WL: Serologic responses to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev. 1998;11:121-141 (Pubitemid 28046018)
30. Kedzierska P, Kochan P, Pietrzyk A, Kedzierska J: Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: Galactomannan, mannan and (1→3)-β-D-glucan antigens. Eur J Clin Microbiol Infect Dis. 2007;26:755-766 (Pubitemid 47573385)
31. Gavett SH, Madison SL, Stevens MA, Costa D: Residual oil fly ash amplifies allergic cytokines, airway responsiveness and inflammation in mice. Am J Respir Crit Care Med. 1999;160:1897-1904 (Pubitemid 30004693)
32. Lambert AL, Dong W, Selgrade MK, Gilmour MI: Enhanced allergic sensitization by residual oil fly ash particles is mediated by soluble metal constituents. Toxicol Appl Pharmacol. 2000;165:84-93 (Pubitemid 30346463)
33. Al-Humadi NH, Siegel PD, Lewis DM, Barger MW, Ma JYC Weissman DN, Ma JKH: The effect of diesel exhaust particles (DEP) and carbon black on thiol changes in pulmonary ovalbumin allergic sensitized Brown Norway rats. Exp Lung Res. 2002;28:333-349 (Pubitemid 34620665)
34. Morishita M, Keeler GJ, Wagner JG, Marsik FJ, Timm EJ Dvonch JT, Harkema JR: Pulmonary retention of particulate matter is associated with airway inflammation in allergic rats exposed to air pollution in urban Detroit. Inhal Toxicol. 2004;16:663-674 (Pubitemid 39121797)
35. Steerenberg PA, Withagen CET, van Dalen WJ, Dormans JAMA, Cassee FR, Heisterkamp SH, van Loveren H: Adjuvant activity of ambient particulate matter of different sites, sizes, and seasons in a respiratory allergymouse model.Toxicol Appl Pharmacol. 2004;200:186-200
36. Lambert AL, Dong W, Winsett DW, Selgrade MK, Gilmour MI: Residual oil fly ash exposure enhances allergic sensitization to house dust mite. Toxicol Appl Pharmacol. 1999;158:269-277 (Pubitemid 29382945)
37. Arantes-Costa FM, Lopes FDTQS, Toldeo AC, Magliarelli- Filho PA, Moriya HT, Carvalho-Oliveira R, Mauad T, Saldiva PHN, Martins MA: Effects of residual oil fly ash (ROFA in mice with chronic allergic pulmonary inflammation. Toxicol Pathol. 2008;36:680-686
38. Wagner JG, Morishita M, Keener GJ, Harkema JR: Divergent effects of urban particulate air pollution on allergic airway responses in experimental asthma: A comparison of filed exposure studies. Environ Health. 2012;11:45
39. Portengen P, Preller L, Tielen M, Doekes G, Heederik D: Endotoxin exposure and atopic sensitization in adult pig farmers. J Allergy Clin Immunol. 2005;115:797-802 (Pubitemid 40460856)
40. Schram-Bijikerk D, Doekes G, Boeve M, Douwes J, Riedler J Ublagger E, von Mutius E, Budde J, Pershagen G, van Hage M, WickmanM, Braun-Fahrländer C,Waser M, Brunekreef B PARSIFAL Study Group: Nonlinear relations between house dust mite allergen levels and mite sensitization in farm and nonfarm children. Allergy. 2006;61:640-647
41. Douwes J, van Strien R, Doekes G, Smit J, Kerkhof M Gerritsen J, Postma D, de Jongste J, Travier N, Brunekreef B: Does early indoor microbial exposure reduce the risk of asthma?
42. The prevention and incidence of asthma and mite allergy birth cohort study. J Allergy Clin Immunol. 2006;117:1067-1073
43. Iossifova YY, Reponen T, Bernstein DI, Levin L, Kalra H Campo P, Villareal M, Lockey J, Hershey GK, LeMasters G: House dust (1-3)-beta-d-glucan and wheezing in infants. Allergy. 2007;62:504-513 (Pubitemid 46608364)